Pityriasis amiantaceahttps://en.wikipedia.org/wiki/Pityriasis_amiantacea
Pityriasis amiantacea bụ ọnọdụ eczematous nke akpụkpọ anụ nke ọnụ ọgụgụ siri ike nke siri ike na-abanye. Ọ naghị ebute ọnya ma ọ bụ alopecia n'ọtụtụ ọnọdụ.

Pityriasis amiantacea na-emetụta isi isi ka akpịrịkpa na-egbuke egbuke. Akpịrịkpa ahụ gbara gburugburu ma na-ekekọta ntutu isi. Enwere ike ịdepụta ọnọdụ ahụ ma ọ bụ kpuchie isi ya niile. Alopecia nwa oge na alopecia na-afụ ụfụ nwere ike ime n'ihi iwepụ ntutu isi ugboro ugboro na-ejikọta na ọnụ ọgụgụ. Ọ bụ ọrịa na-adịghị ahụkebe.

Ọgwụgwọ ― OTC Ọgwụ
* Ngwa keratolytic nwere urea nwere ike inye aka gwọọ oke oke.
#40% urea cream

* Jiri ncha ntutu na-egbochi ọfụfụ kwa ụbọchị.
#Ciclopirox shampoo
#Ketoconazole shampoo
#Fluocinolone shampoo
#Pyrithione zinc shampoo
#Selenium sulfide shampoo

* Tinye ọgwụ steroid OTC naanị n'akụkụ ihe na-afụ ụfụ nke isi isi. Mara na itinye nnukwu steroid n'isi nwere ike ibute folliculitis.
#Hydrocortisone cream
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
      References Pityriasis amiantacea - Case reports 25506575 
      NIH
      Otu nwata nwoke dị afọ iri na anọ ji akpịrịkpa gbara agba na-acha odo odo na-acha odo odo batara n'isi ya, ọkachasị n'ihu na n'elu. Ebe ndị ahụ metụtara na-acha uhie uhie na akpụkpọ anụ, na-enwe ntutu isi mana ọ nweghị ọnyà. Nlele maka ero dị njọ.
      A 14-year-old male patient presented with focal masses of thick, adherent, plate like, yellow-brown scales, attached to the hair shafts, predominantly affecting the fronto-parietal area and vertex of the scalp. The underlying scalp had thick, erythematous plaques with fine, non greasy, silvery-white scaling with noncicatricial alopecia. Potassium hydroxide examination of scales and hair and culture for fungus was negative.
       Pityriasis amiantacea: a study of seven cases 27828657 
      NIH
      The disease may be secondary to any skin condition that primarily affects the scalp, including seborrheic dermatitis. Its pathogenesis remains uncertain. We aim to analyze the epidemiological and clinical profiles of patients with pityriasis amiantacea to better understand treatment responses. We identified seven cases of pityriasis amiantacea and a female predominance in a sample of 63 pediatric patients with seborrheic dermatitis followed for an average of 20.4 months. We reported a mean age of 5.9 years. Five patients were female, with a mean age of 9 years. All patients were successfully treated with topic ketoconazole.